Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers
Authors:
- Nora DellepianeNDNora Dellepiane
- Sonia PagliusiSPSonia Pagliusi
- Prashant AkutPAPrashant Akut
- Sebastian ComellasSCSebastian Comellas
- Norbert De ClercqNCNorbert De Clercq
- Shubhangi GhadgeSGShubhangi Ghadge
- Thierry GastineauTGThierry Gastineau
- Mic McGoldrickMMMic McGoldrick
- Ida NurnaeniINIda Nurnaeni
- Lorenz SchepplerLSLorenz Scheppler
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Vaccine: X
- Vol. 6
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation
This publication has 7 references indexed in Scilit:
- Opportunities for improving access to vaccines in emerging countries through efficient and aligned registration procedures: An industry perspectiveVaccine, 2019
- Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systemsGlobalization and Health, 2018
- Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processesVaccine, 2018
- Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market AuthorizationPLOS ONE, 2016
- History of Sabin attenuated poliovirus oral live vaccine strainsJournal of Biological Standardization, 1973
- Studies on an Attenuated Measles-Virus VaccineNew England Journal of Medicine, 1960
- THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATIONJournal of Experimental Medicine, 1937